Turing cuts jobs, looks for new CEO after Shkreli left

Shkreli resigned Friday, a day after his arrest on charges of securities fraud related to a company he previously ran

• Dec 23, 2015

Martin Shkreli out at another drug company

KaloBios says it canned the controversial hedge fund investor the day he was arrested and charged with securities fraud

• Dec 21, 2015

Shkreli takes to Twitter to speak out on charges

Feds accuse controversial ex-CEO of looting pharmaceutical company he founded to pay back disgruntled hedge fund clients

• Dec 19, 2015

Martin Shkreli resigns from Turing Pharmaceuticals

A day after his arrest on securities fraud charges, the boyish entrepreneur who drew public ire, steps down

• Dec 18, 2015

Feds: Shkreli ran companies like a Ponzi scheme

Authorities accuse former hedge fund manager who jacked up price of life-saving drug of weaving "outrageous web of lies"

• Dec 17, 2015

For Martin Shkreli, suspicions going back years

Now charged with running a Ponzi scheme, controversial pharmaceutical executive was previously accused of market misdeeds

• Dec 17, 2015

On social media, Shkreli's arrest draws cheers

Some say it is "karma" that the poster boy for corporate and Wall Street greed has been indicted for securities fraud

• Dec 17, 2015

Pharma CEO Martin Shkreli arrested on securities fraud

Shkreli drew criticism earlier this year for raising the price of a life-saving pill by more than 5,000 percent

• Dec 17, 2015

CEO reviled for drug price hike charged with securities fraud

Martin Shkreli became a poster boy for Wall Street greed when he raised the cost of a life-saving pill from $13.50 to $750

• Dec 17, 2015

Martin Shkreli bought Wu-Tang record for $2 million

Taylor Swift can listen to it if she wants

• Dec 9, 2015

Martin Shkreli: I should've "raised prices higher"

The guy who hiked the cost of a life-saving drug 5,000 percent says if he could do it all over again, he'd hike prices even more

• Dec 4, 2015

Reining in the rising cost of some prescription drugs

Some pharmaceutical companies are making their own version of pricey prescriptions, saying they only want to make "an ethical profit"

• Dec 1, 2015

​5 reasons why Americans pay so much for drugs

Other countries pay far less for prescription meds than the U.S. -- blame lots of marketing and a lack of bargaining

• Dec 1, 2015

Express Scripts offers $1 alternative to $750 pill

After drug company's owner announced a 5,000-percent price hike earlier this year, a less expensive option will soon be available

• Dec 1, 2015

Will company selling lifesaving drug for $1 still make a profit?

Company to sell cheaper version of drug for cancer, AIDS patients after global uproar over competitor drastically raising price

• Nov 28, 2015

Turing cuts 5,000% drug price hike to 2,500%

Pharma firm's latest response to backlash over infamous price spike includes discounts of "up to 50 percent" for hospitals

• Nov 25, 2015

KaloBios stock rockets after investment from Shkreli

Former hedge fund manager takes majority stake in drug developer that planned to wind down operations

• Nov 19, 2015

Company to offer $1 version of costly Turing drug

Drug compounder says it will make low-cost capsule that contains the active ingredients found in Daraprim

• Oct 22, 2015

New York AG probes drugmaker accused of price gouging

Regulator looking at whether Turing Pharmaceuticals violated antitrust rules by hiking price of a 62-year-old drug by nearly 5,000 percent

• Oct 13, 2015

The real reason U.S. drug prices are so high

Pharmaceutical companies typically say costs support R&D, but a look at their financials show that's not the case

• Oct 7, 2015

Controversial drug company CEO once sued for harassment

Turing Pharmaceuticals CEO Martin Shkreli also sued by former company for $65 million for using firm "to enrich himself"

• Sep 23, 2015

CEO promises to lower controversial price of key drug

The 5,000-percent overnight price hike on a crucial infection treatment drug created outrage that Turing Pharmaceuticals initially dismissed

• Sep 23, 2015

Meet the moneyman behind a controversial prescription price hike

Turing Pharmaceuticals CEO Martin Shkreli has come under fire before for sharply raising the cost of a medication decades after it was created

• Sep 22, 2015

CEO: 5,000-percent drug price hike "not excessive at all"

Turing Pharmaceuticals got control of a crucial infection treatment drug called Daraprim in August, and immediately raised the price from $13.50 to $750

• Sep 22, 2015